Kretto Syscon Ltd
BSE:531328
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kretto Syscon Ltd
BSE:531328
|
IN |
|
L
|
Lokotech Group AS
OSE:LOKO
|
NO |
|
M
|
MindBio Therapeutics Corp
CNSX:MBIO
|
CA |
|
R
|
Rhoen Klinikum AG
SWB:RHK
|
DE |
Balance Sheet
Balance Sheet Decomposition
Kretto Syscon Ltd
Kretto Syscon Ltd
Balance Sheet
Kretto Syscon Ltd
| Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
1
|
1
|
2
|
4
|
3
|
0
|
2
|
3
|
4
|
0
|
36
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
0
|
2
|
3
|
4
|
0
|
35
|
|
| Cash Equivalents |
0
|
0
|
0
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
2
|
2
|
0
|
0
|
56
|
0
|
27
|
2
|
0
|
0
|
0
|
0
|
0
|
76
|
|
| Accounts Receivables |
2
|
1
|
0
|
0
|
56
|
0
|
27
|
2
|
0
|
0
|
0
|
0
|
0
|
76
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
1
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
7
|
|
| Total Current Assets |
2
|
2
|
0
|
2
|
57
|
17
|
33
|
6
|
1
|
2
|
3
|
4
|
1
|
119
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
8
|
|
| Note Receivable |
0
|
0
|
11
|
159
|
0
|
146
|
153
|
156
|
161
|
165
|
169
|
164
|
177
|
557
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Total Assets |
2
N/A
|
2
-26%
|
11
+553%
|
161
+1 350%
|
201
+25%
|
185
-8%
|
193
+5%
|
170
-12%
|
170
0%
|
175
+3%
|
179
+3%
|
176
-2%
|
185
+5%
|
705
+281%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
40
|
30
|
35
|
11
|
10
|
10
|
11
|
6
|
3
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
1
|
1
|
4
|
5
|
5
|
5
|
16
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
41
|
31
|
38
|
12
|
11
|
14
|
16
|
11
|
18
|
16
|
|
| Long-Term Debt |
3
|
2
|
11
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
2
-24%
|
11
+495%
|
0
-97%
|
44
+14 435%
|
31
-28%
|
38
+20%
|
12
-68%
|
11
-9%
|
14
+21%
|
17
+22%
|
11
-33%
|
18
+65%
|
27
+46%
|
|
| Equity | |||||||||||||||
| Common Stock |
45
|
45
|
2
|
102
|
143
|
143
|
143
|
143
|
143
|
143
|
157
|
157
|
157
|
627
|
|
| Retained Earnings |
46
|
46
|
2
|
48
|
15
|
11
|
13
|
16
|
16
|
18
|
6
|
8
|
10
|
52
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
-50%
|
161
N/A
|
157
-2%
|
153
-2%
|
156
+1%
|
158
+2%
|
159
+0%
|
161
+1%
|
163
+1%
|
165
+1%
|
167
+2%
|
679
+306%
|
|
| Total Liabilities & Equity |
2
N/A
|
2
-26%
|
11
+553%
|
161
+1 350%
|
201
+25%
|
185
-8%
|
193
+5%
|
170
-12%
|
170
0%
|
175
+3%
|
179
+3%
|
176
-2%
|
185
+5%
|
705
+281%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
4
|
4
|
4
|
226
|
226
|
226
|
226
|
226
|
226
|
226
|
226
|
226
|
226
|
677
|
|